![]() ![]() ALK gene rearrangement for diffuse large B cell lymphoma, anaplastic thyroid carcinoma, primary cutaneous CD30+ T-cell lymphoproliferative disorders, post-transplant lymphoproliferative disorder, and non-small cell lung cancer.ALK gene fusion as a molecular biomarker in non-small cell lung cancer.ALK expression for pancreatic adenocarcinoma, pediatric Hodgkin's lymphoma, inflammatory myofibroblastic tumor (IMT) with ALK translocation, breast implant-associated ALCL, peripheral T-cell lymphoma, and uterine sarcoma.Repeat testing is considered experimental and investigational ![]() ![]() Afirma Thyroid FNA analysis for assessing fine needle aspiration samples from thyroid nodules that are indeterminate experimental for other indications.5-hydroxyindoleacetic acid (5-HIAA) for neuroendocrine tumors.1p19q codeletion molecular cytogenetic analysis for astrocytomas and gliomas.This Clinical Policy Bulletin addresses tumor markers, including somatic (acquired) mutations, in oncology.įor criteria related to germline (inherited) mutations, see CPB 0140 - Genetic Testing.Īetna considers any of the following tumor markers for the stated indication medically necessary: Number: 0352 Table Of Contents Policy Applicable CPT / HCPCS / ICD-10 Codes Background References
0 Comments
Leave a Reply. |